R Kent McGaughy Jr insider trades

Open-market stock purchases and sales by R Kent McGaughy Jr, Director at Instil Bio, Inc, from SEC Form 4 filings since Jun 1, 2016.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -60%.

Recent trades

DateStockTradeValue
Jun 11, 2026TIL Instil Bio, IncBought (not open market)—

Companies traded

  • TIL Instil Bio, Inc: 1 buy, last Jun 11, 2026
  • PRCT PROCEPT BioRobotics Corp: other filings, last May 3, 2024
  • RETA Reata Pharmaceuticals Inc: 37 buys, last Sep 26, 2023
  • APEN Apollo Endosurgery, Inc: 14 buys, last Apr 4, 2023

Get free alerts when R Kent McGaughy Jr files a new trade →